LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 1 of total 1

Search options

Article ; Online: Cardiac sequelae after coronavirus disease 2019 recovery: a systematic review.

Ramadan, Mohammad Said / Bertolino, Lorenzo / Zampino, Rosa / Durante-Mangoni, Emanuele

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases

2021  Volume 27, Issue 9, Page(s) 1250–1261

Abstract: Background: Coronavirus disease 2019 (COVID-19) has been implicated in a wide spectrum of cardiac ... manifestations after COVID-19 recovery.: Exposure: Severe acute respiratory syndrome coronavirus 2 infection ... manifestations following the acute phase of the disease.: Objectives: To assess the range of cardiac sequelae ...

Abstract Background: Coronavirus disease 2019 (COVID-19) has been implicated in a wide spectrum of cardiac manifestations following the acute phase of the disease.
Objectives: To assess the range of cardiac sequelae after COVID-19 recovery.
Data sources: PubMed, Embase, Scopus (inception through 17 February 2021) and Google scholar (2019 through 17 February 2021).
Study eligibility criteria: Prospective and retrospective studies, case reports and case series.
Participants: Adult patients assessed for cardiac manifestations after COVID-19 recovery.
Exposure: Severe acute respiratory syndrome coronavirus 2 infection diagnosed by PCR.
Methods: Systematic review.
Results: Thirty-five studies (fifteen prospective cohort, seven case reports, five cross-sectional, four case series, three retrospective cohort and one ambidirectional cohort) evaluating cardiac sequelae in 52 609 patients were included. Twenty-nine studies used objective cardiac assessments, mostly cardiac magnetic resonance imaging (CMR) in 16 studies, echocardiography in 15, electrocardiography (ECG) in 16 and cardiac biomarkers in 18. Most studies had a fair risk of bias. The median time from diagnosis/recovery to cardiac assessment was 48 days (1-180 days). Common short-term cardiac abnormalities (<3 months) included increased T1 (proportion: 30%), T2 (16%), pericardial effusion (15%) and late gadolinium enhancement (11%) on CMR, with symptoms such as chest pain (25%) and dyspnoea (36%). In the medium term (3-6 months), common changes included reduced left ventricular global longitudinal strain (30%) and late gadolinium enhancement (10%) on CMR, diastolic dysfunction (40%) on echocardiography and elevated N-terminal proB-type natriuretic peptide (18%). In addition, COVID-19 survivors had higher risk (risk ratio 3; 95% CI 2.7-3.2) of developing heart failure, arrythmias and myocardial infarction.
Conclusions: COVID-19 appears to be associated with persistent/de novo cardiac injury after recovery, particularly subclinical myocardial injury in the earlier phase and diastolic dysfunction later. Larger well-designed and controlled studies with baseline assessments are needed to better measure the extent of cardiac injury and its clinical impact.
MeSH term(s) Adult ; COVID-19/complications ; COVID-19/diagnosis ; COVID-19 Nucleic Acid Testing ; Echocardiography ; Electrocardiography ; Heart Diseases/epidemiology ; Heart Diseases/etiology ; Humans ; Magnetic Resonance Imaging, Cine ; SARS-CoV-2/genetics ; SARS-CoV-2/isolation & purification
Language English
Publishing date 2021-06-23
Publishing country England
Document type Journal Article ; Systematic Review
ZDB-ID 1328418-6
ISSN 1469-0691 ; 1470-9465 ; 1198-743X
ISSN (online) 1469-0691
ISSN 1470-9465 ; 1198-743X
DOI 10.1016/j.cmi.2021.06.015
Shelf mark
Zs.A 4541: Show issues Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (2.OG)
ab Jg. 2022: Lesesaal (EG)
Zs.MO 284: Show issues
Database MEDical Literature Analysis and Retrieval System OnLINE

More links

Kategorien

To top